Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
17.97
-0.30 (-1.64%)
At close: Jul 6, 2026, 4:00 PM EDT
18.06
+0.09 (0.50%)
Pre-market: Jul 7, 2026, 8:22 AM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $2 billion as of July 7, 2026. Its market cap has increased by 339.49% in one year.
Market Cap
2.00B
Enterprise Value
1.72B
1-Year Change
339.49%
Ranking
Category
Stock Price
$17.97
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $2.00B, an increase of 86.87%. That is a compound annual growth rate of 14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 2.00B | 50.61% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.79B |
| BioCryst Pharmaceuticals | 2.50B |
| Prestige Consumer Healthcare | 2.34B |
| HUTCHMED (China) | 2.04B |
| Trulieve Cannabis | 1.88B |
| Bausch Health Companies | 1.83B |
| ANI Pharmaceuticals | 1.82B |
| Harrow | 1.59B |